BIOCRYST PHARMACEUTICA
7.7800
08-11月-24 15:59:59
15 分の遅延
株式
+0.1100
+1.43%
本日の幅
7.5200 - 7.8400
ISIN
N/A
ソース
NASDAQ
-
29 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
21 11 2023 16:01:44 提供 Nasdaq GlobeNewswire
-
BioCryst Launches ORLADEYO® (berotralstat) in Spain
21 11 2023 07:00:13 提供 Nasdaq GlobeNewswire
-
10 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 11 2023 16:01:28 提供 Nasdaq GlobeNewswire
-
03 11 2023 12:03:00 提供 Nasdaq GlobeNewswire
-
03 11 2023 12:00:00 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Third Quarter 2023 Financial Results and Provides Business Update
02 11 2023 07:00:55 提供 Nasdaq GlobeNewswire
-
27 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
26 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
BioCryst to Host R&D Day on November 3
20 10 2023 07:00:08 提供 Nasdaq GlobeNewswire
-
BioCryst to Report Third Quarter 2023 Financial Results on November 2
19 10 2023 07:00:16 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 10 2023 07:00:41 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 9 2023 07:00:46 提供 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
23 8 2023 16:01:54 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 8 2023 16:01:28 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Second Quarter 2023 Financial Results and Provides Business Update
03 8 2023 07:00:58 提供 Nasdaq GlobeNewswire
-
BioCryst to Report Second Quarter 2023 Financial Results on August 3
20 7 2023 07:00:37 提供 Nasdaq GlobeNewswire
-
BioCryst Selects Er-Kim Pharmaceuticals as Commercial Partner for ORLADEYO® (berotralstat) in Turkey
19 7 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
BioCryst to Participate in the 2023 US HAEA National Summit
17 7 2023 07:00:00 提供 Nasdaq GlobeNewswire